You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. IND- and NDA-enabling toxicology studies for PTI-125, a novel small molecule for Alzheimer's disease

    SBC: PAIN THERAPEUTICS, INC.            Topic: NIA

    DESCRIPTION provided by applicant PTI is a novel compound with a novel target designed to treat and slow the progression of Alzheimerandapos s disease AD PTI works by binding extremely tightly to a particular site on filamin A FLNA a protein we recently demonstrated to be critical to beta amyloidandapos s toxicity Beta amyloid A exerts its toxic effects by binding and h ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  2. Real-time 3D Imaging Guided ART

    SBC: Xyken, LLC            Topic: 100

    DESCRIPTION provided by applicant The United States have the highest annual incidence rates of breast cancer in the word It is the second most common cancer after skin cancer and the second most common cause of cancer death after lung cancer It is estimated that in there will be an estimated new cancer cases diagnosed and cancer deaths in the US Worldwide more ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  3. PREDICTABLE REAL-TIME MULTIPROCESSING IN AIRBORNE SYSTEMS

    SBC: Unisoft Consulting Inc            Topic: N/A

    N/A

    SBIR Phase I 1996 National Aeronautics and Space Administration
  4. Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia

    SBC: Xeris Pharmaceuticals, Inc.            Topic: NIDDK

    DESCRIPTION provided by applicant The objective of this Fast Track program is to develop a novel stable non aqueous glucagon formulation with an infusion pump system in closed loop with continuous glucose monitoring for treatment of post bariatric surgery patients who have experienced repetitive severe postprandial hypoglycemia This approach will provide a automated or semi automated gluc ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  5. Auto-Injectable Diazepam Formulation for Rapid Treatment of Uncontrolled Seizures

    SBC: Xeris Pharmaceuticals, Inc.            Topic: NINDS

    DESCRIPTION provided by applicant The program outlined in this Fast Track application has been designed to accelerate the development and commercialization of the DiazePen tm for the treatment of uncontrolled seizures in persons with epilepsy The envisioned product would replace the current standard of care diazepam rectal gel DiaStat r with a novel formulation fo rapid delivery via subc ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  6. SECONDARY PREVENTION OF ALCOHOLISM VIA COMPUTER SOFTWARE

    SBC: Alcohol Self-control Program            Topic: N/A

    N/A

    SBIR Phase I 1990 Department of Health and Human Services
  7. CSI Glucagon for Treatment of Congenital Hyperinsulinism

    SBC: Xeris Pharmaceuticals, Inc.            Topic: 200

    DESCRIPTION provided by applicant The objective of this program is to further the development of a novel stable non aqueous glucagon formulation CSI continuous subcutaneous infused Glucagon tm in combination with a Insulet OmniPod r infusion pump for prevention of hypoglycemia in patients with congenital hyperinsulinism HI The addition of glucagon will meet a significant unmet need i ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. Development of a human physiological multi-cellular liver platform for drug-induced liver injury and disease.

    SBC: HemoShear Therapeutics, LLC            Topic: 300

    DESCRIPTION provided by applicant Liver cell based systems are widely used to study drug metabolism toxicity and liver disease However the poor correlation between in vitro data and clinical outcomes is very real and attributed in part to the missing physiological context of the hepatic microenvironment sinusoidal flow and transport three dimensional architecture and heterotypic cell cell ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Development of a Broad Spectrum Antiviral for Ebola and Marburg viral Infections

    SBC: Omm Scientific, Inc            Topic: NIAID

    DESCRIPTION provided by applicant The long term goal of this project is to gain FDA approval for commercialization of a broad spectrum small molecule antiviral agent that is effective in treating Ebola virus EBOV and Marburg virus MARV These pathogens are major biothreat agents for which there are no approved therapeutic options or vaccines The developed drug will inhibit a conserved hum ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. An Integrated Microarray Printing and Detection System

    SBC: BIOSENSING INSTRUMENT INC            Topic: 400

    DESCRIPTION provided by applicant Microarray technology has dramatically advanced the study of protein interactions leading to discovery and validation of new biomarkers and therapeutic drugs Typically protein microarrays are pre spotted with target molecules in one device and then tested with probe molecules using another device During each testing cycle the entire microarray becomes expos ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government